TickerFacts.

Liquidia Corp (LQDA): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$1.53M
Year ended 2025-12-31
$1.69M
Trailing 12 months to 2026-06-30
-25.2%
3-year compound annual growth
-13.4%
5-year compound annual growth
$5.61M2019-12-31: $2.57M2020-12-31: $3.13M2021-12-31: $5.61M2022-12-31: $3.65M2023-12-31: $2.18M2024-12-31: $2.20M2025-12-31: $1.53M$1.53M
2019-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$1.53M-30.5%2026-03-05, From 2025-01-01
2024-12-31$2.20M+0.9%2026-03-05, From 2024-01-01
2023-12-31$2.18M-40.3%2026-03-05, From 2023-01-01
2022-12-31$3.65M-35.0%2024-03-13, From 2022-01-01
2021-12-31$5.61M+79.3%2023-03-20, From 2021-01-01
2020-12-31$3.13M+21.9%2022-03-17, From 2020-01-01
2019-12-31$2.57Mn/a2021-03-25, From 2019-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Liquidia Corp (LQDA)2025-12-31$1.53M-30.5%
Heron Therapeutics, Inc. (HRTX)2025-12-31$2.31M-7.1%
Macrogenics Inc (MGNX)2025-12-31$7.17M-4.9%
Elite Pharmaceuticals Inc (ELTP)2026-03-31$1.07M-12.6%
Phathom Pharmaceuticals, Inc. (PHAT)2025-12-31$633.0K-20.4%
Cryoport, Inc. (CYRX)2025-12-31$27.71M-9.9%
Lifevantage Corp (LFVN)2026-06-30$2.77M-12.1%
Rhythm Pharmaceuticals, Inc. (RYTM)2025-12-31$500.0K-28.6%
Lifecore Biomedical, Inc. (LFCR)2025-05-25$8.03M+0.9%

Compare LQDA, HRTX, MGNX, ELTP side by side · Screen every company in Pharmaceutical Preparations ↗